MicroRNA‐125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2

• Published in: Hepatology (Baltimore, Md.) Vol. 52; no. 5; pp. 1731 - 1740
• Main Authors: Liang, Linhui, Wong, Chun‐Ming, Ying, Qiao, Fan, Dorothy Ngo‐Yin, Huang, Shenglin, Ding, Jie, Yao, Jian, Yan, Mingxia, Li, Jinjun, Yao, Ming, Ng, Irene Oi‐Lin, He, Xianghuo
• Format: Journal Article
• Language: English
• Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.11.2010; Wolters Kluwer Health, Inc
• Subjects: Cell cycle; Cell Cycle - drug effects; Cell Division - drug effects; Cell growth; Cell Movement - drug effects; Colony-Forming Units Assay; DNA-Binding Proteins - antagonists & inhibitors; DNA-Binding Proteins - drug effects; Down-Regulation; Flow Cytometry; Gene Expression Regulation, Neoplastic; Genes, Reporter; Hepatology; Humans; Liver cancer; Liver Neoplasms - genetics; Liver Neoplasms - pathology; MicroRNAs - genetics; MicroRNAs - pharmacology; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - drug effects; RNA, Messenger - genetics; RNA-Binding Proteins; Transfection
• ISSN: 0270-9139; 1527-3350; 1527-3350
• DOI: 10.1002/hep.23904

MicroRNAs (miRNAs) are small, noncoding RNAs that can act as oncogenes or tumor suppressors in human cancer. Our previous study showed that miR‐125b was a prognostic indicator for patients with hepatocellular carcinoma (HCC), but its functions and exact mechanisms in hepatic carcinogenesis are still unknown. Here we demonstrate that miR‐125b suppressed HCC cell growth in vitro and in vivo. Moreover, miR‐125b increased p21Cip1/Waf1 expression and arrested cell cycle at G1 to S transition. In addition, miR‐125b inhibited HCC cell migration and invasion. Further studies revealed that LIN28B was a downstream target of miR‐125b in HCC cells as miR‐125b bound directly to the 3′ untranslated region of LIN28B, thus reducing both the messenger RNA and protein levels of LIN28B. Silencing of LIN28B recapitulated the effects of miR‐125b overexpression, whereas enforced expression of LIN28B reversed the suppressive effects of miR‐125b. Conclusion: These findings indicate that miR‐125b exerts tumor‐suppressive effects in hepatic carcinogenesis through the suppression of oncogene LIN28B expression and suggest a therapeutic application of miR‐125b in HCC. (HEPATOLOGY 2010)